GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
| Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
| First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
| Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
| Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
| CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
| PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
| Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
| Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |